PROGYNY, INC. (PGNY): Price and Financial Metrics
GET POWR RATINGS... FREE!
PGNY POWR Grades
- Sentiment is the dimension where PGNY ranks best; there it ranks ahead of 60.73% of US stocks.
- PGNY's strongest trending metric is Quality; it's been moving up over the last 179 days.
- PGNY ranks lowest in Value; there it ranks in the 10th percentile.
PGNY Stock Summary
- With a price/earnings ratio of 82.67, PROGYNY INC P/E ratio is greater than that of about 93.97% of stocks in our set with positive earnings.
- The price/operating cash flow metric for PROGYNY INC is higher than 95.9% of stocks in our set with a positive cash flow.
- The ratio of debt to operating expenses for PROGYNY INC is higher than it is for about just 10.74% of US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to PROGYNY INC are EXPI, MFH, TWKS, FAMI, and GENI.
- PGNY's SEC filings can be seen here. And to visit PROGYNY INC's official web site, go to www.progyny.com.
PGNY Valuation Summary
- In comparison to the median Technology stock, PGNY's EV/EBIT ratio is 830.77% higher, now standing at 169.4.
- Over the past 37 months, PGNY's price/sales ratio has gone down 3.3.
Below are key valuation metrics over time for PGNY.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| PGNY | 2022-11-14 | 4.9 | 9.9 | 81.4 | 169.4 |
| PGNY | 2022-11-11 | 5.0 | 10.2 | 84.0 | 174.9 |
| PGNY | 2022-11-10 | 5.0 | 10.1 | 83.2 | 173.3 |
| PGNY | 2022-11-09 | 5.0 | 10.1 | 83.2 | 173.3 |
| PGNY | 2022-11-08 | 5.4 | 11.0 | 90.7 | 189.1 |
| PGNY | 2022-11-07 | 5.4 | 10.8 | 89.2 | 185.9 |
PGNY's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- PGNY has a Quality Grade of B, ranking ahead of 85.19% of graded US stocks.
- PGNY's asset turnover comes in at 1.694 -- ranking 4th of 81 Healthcare stocks.
- 500 - Internal server error
The table below shows PGNY's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-06-30 | 1.694 | 0.222 | 0.251 |
| 2021-03-31 | 1.663 | 0.213 | 0.173 |
| 2020-12-31 | 1.695 | 0.203 | 0.146 |
| 2020-09-30 | 1.744 | 0.198 | 0.078 |
| 2020-06-30 | 1.873 | 0.194 | -0.499 |
PGNY Price Target
For more insight on analysts targets of PGNY, see our PGNY price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $65.50 | Average Broker Recommendation | 1.25 (Strong Buy) |
PGNY Stock Price Chart Interactive Chart >
PGNY Price/Volume Stats
| Current price | $34.38 | 52-week high | $53.56 |
| Prev. close | $34.32 | 52-week low | $25.67 |
| Day low | $33.79 | Volume | 277,300 |
| Day high | $34.69 | Avg. volume | 735,316 |
| 50-day MA | $38.44 | Dividend yield | N/A |
| 200-day MA | $38.25 | Market Cap | 3.19B |
PROGYNY, INC. (PGNY) Company Bio
Progyny, Inc. is a medical device company, which engages in the field of reproductive medicine, translating scientific discoveries related to early embryo development into clinical tools. Its services include egg freezing, IVF treatment, surrogacy, podcast, adoption, and Eeva Test. The company was founded on April 03, 2008 and is headquartered in New York, NY.
Latest PGNY News From Around the Web
Below are the latest news stories about PROGYNY INC that investors may wish to consider to help them evaluate PGNY as an investment opportunity.
Does Progyny (PGNY) Have High Growth Prospects?ClearBridge Investments, an investment management company, released its “ClearBridge Sustainability Leaders Strategy” third 2022 investor letter. A copy of the same can be downloaded here. The strategy outperformed its benchmark in the third quarter, the Russell 3000 Index. Only the industrial sector contributed positively to the strategy’s absolute performance among the ten sectors the strategy invested […] |
ELV or PGNY: Which Is the Better Value Stock Right Now?ELV vs. PGNY: Which Stock Is the Better Value Option? |
Progyny Recent Insider ActivityTPG GP A, LLC , 10% Owner at Progyny (NASDAQ: PGNY ), reported a large insider sell on November 9, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that LLC sold 750,000 shares of Progyny . The total transaction amounted to $29,062,500. Progyny shares are trading down 0.0% at $37.66 at the time of this writing on Thursday morning. Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm. Why Insider Transactions Are Important Insider transactions shouldn''t be used primarily to make … Full story available on Benzinga.com |
Progyny Third Quarter 2022 Earnings: Beats ExpectationsProgyny ( NASDAQ:PGNY ) Third Quarter 2022 Results Key Financial Results Revenue: US$205.4m (up 68% from 3Q 2021). Net... |
Progyny Inc. (NASDAQ: PGNY) Jumps 2.99% In Recent Session, What Are The Points You Absolutely Need To Consider?Progyny Inc. (NASDAQ:PGNY) price closed higher on Monday, November 07, jumping 2.99% above its previous close. A look at the daily price movement shows that the last close reads $39.19, with intraday deals fluctuated between $38.94 and $41.45. The company’s 5Y monthly beta was ticking 1.96 while its P/E ratio in the trailing 12-month period … Progyny Inc. (NASDAQ: PGNY) Jumps 2.99% In Recent Session, What Are The Points You Absolutely Need To Consider? Read More » |
PGNY Price Returns
| 1-mo | -16.86% |
| 3-mo | -17.49% |
| 6-mo | N/A |
| 1-year | -32.68% |
| 3-year | 27.38% |
| 5-year | N/A |
| YTD | -31.72% |
| 2021 | 18.78% |
| 2020 | 54.43% |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
Loading social stream, please wait...